Determination of Cut-Off Index of Reactive HBsAg Based on Confirmatory Test at Dr. Moewardi Hospital

Authors

  • Ellya Latifah Ilyas Department of Clinical Pathology, Faculty of Medicine, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta
  • JB. Suparyatmo Department of Clinical Pathology, Faculty of Medicine, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta
  • Amiroh Kurniati Department of Clinical Pathology, Faculty of Medicine, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta

DOI:

https://doi.org/10.24293/ijcpml.v28i1.1726

Keywords:

Cut-off index, false-reactive, ECLIA

Abstract

HBsAg confirmatory test is required to confirm false reactive HBsAg due to non-specific binding of antigen with antibody. HBsAg confirmatory test cannot be performed in every laboratory due to the high price of reagents, short reagent shelf life, prolonged turnaround time, and increasing complexity of the test. This study aimed to determine the HBsAg COI (cut-off unit) cut-off point, which requires a confirmatory HBsAg test on the COBAS e411 analyzer with the ECLIA method. An observational analytic study with a cross-sectional approach was performed on 59 patients who underwent the HBsAg test at Dr. Moewardi Hospital, Surakarta in September-October 2020 on the Cobas e411 analyzer with the ECLIA method. The best analytical performance of cut-off index of reactive HBsAg was determined using the ROC curve and AUC. The results of initial HBsAg COI showed the following results: borderline with a mean: 0.975±0.0014 and reactive with a median of 4.38 (1.03-10)). The confirmatory test showed 59.8% reactive, 22.2% non-reactive, 13.8% not valid and 4.2% indeterminate results. The cut-off value for reactive HBsAg was 4.34 with an AUC of 0.818 (95% CI: 0.713 - 0.923; p=0.054), a sensitivity of 72.1% and a specificity of 87.5%. The initial cut-off of HBsAg index at 4.34 COI showed the best analytical performance with a sensitivity of 72.1% and specificity of 87.3%. Therefore, it can be used to determine HBsAg results that require HBsAg confirmatory examination on the Cobas e411 analyzer with the ECLIA method.

Downloads

Download data is not yet available.

Author Biographies

Ellya Latifah Ilyas, Department of Clinical Pathology, Faculty of Medicine, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta

Department of Clinical Pathology, Faculty of Medicine, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta

JB. Suparyatmo, Department of Clinical Pathology, Faculty of Medicine, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta

Department of Clinical Pathology, Faculty of Medicine, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta

Amiroh Kurniati, Department of Clinical Pathology, Faculty of Medicine, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta

Department of Clinical Pathology, Faculty of Medicine, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta

References

Purnamawaty S, Handayani I, Nurulita A, Bahrun U. Determination of reactive HBsAg cut-off that need

confirmatory test. Indonesian Journal of Clinical Pathology and Medial Laboratory, 2018; 24(3): 298-300.

Latuconsina VZ, Handayani I, Nurulita A, Bahrun U. 2018. Determination of gray zone range in HBsAg test and its implication for HBsAg confirmation test. Indonesian Journal of Clinical Pathology and Medical Laboratory, 2018; 24(2): 127-130.

Roche. Elecsys HBsAg confirmatory test. Mannhamin, Germany, Roche Diagnostic GmbH. 2018. Available from: www.roche.com (accessed May 20, 2020).

Candotti D, Laperche S. Hepatitis B virus blood screening: Need for reappraisal of blood safety

measures?. Frontiers in Medicine, 2018; 29(5): 1-8.

Ghai S, Dutta P. Comparative evaluation of E l e c t r o c h e m i l u m i n e s c e n c e ( E C L I A ) w i t h

Immunochromatographic Test (ICT) available for hepatitis B surface antigen. Galore International

Journal of Health Sciences and Research, 2018; 3(3): 43-46.

Shao H, Li Y, Xu W-Z, Zhou X. Increased need for testing to confirm initial weakly reactive result for

hepatitis B virus surface antigen. Lab Medicine, 2012; 43(4): 15-17.

Pyrsopoulos NT, Reddy KR, Talavera F, Anand BS, Wu GY. Hepatitis B. 2018. Available from: https://

emedicine.medscape.com/article/177632-overview (accessed May 18, 2020).

Khoo BZE, Tan ZK, Boxall MC, Bairy M. False-positive hepatitis B antigenemia after vaccination in patient with CKD. Kidney International Report, 2021; 6: 2237-2239.

Kementerian Kesehatan Republik Indonesia. Pedoman pelayanan laboratorium pemeriksaan hepatitis. Jakarta Selatan, Kementerian Kesehatan RI, 2015; 25-51.

Reuschel E, Jilg W, Seelbach-Goebel B, Demi L. Comparative purification and characterization of

Hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells

and human primary hepatocytes. PLos One, 2019; 14(2): 1-18.

World Health Organization. Guidelines on hepatitis B and C testing. Geneva, World Health Organization, 2017; 108-109.

Bashir R, Sharif MH, Vidhya, Saxena V. Hepatitis B s u r f a c e a n t i g e n d e t e c t i o n b y e n h a n c e chemiluminescence, a pilot study to determine the gray zone result. International Journal of Current

Microbiology and Applied Sciences, 2016; 5(10): 778-782.

Downloads

Submitted

2020-11-06

Accepted

2021-09-07

Published

2021-12-15

How to Cite

[1]
Ilyas, E.L., Suparyatmo, J. and Kurniati, A. 2021. Determination of Cut-Off Index of Reactive HBsAg Based on Confirmatory Test at Dr. Moewardi Hospital. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 28, 1 (Dec. 2021), 31–35. DOI:https://doi.org/10.24293/ijcpml.v28i1.1726.

Issue

Section

Articles